- ￥8400
- AntibodySystem
- 0.31-5 μg/mL
- 0.156 μg/ml
- France
- KDC90703
- 2025年12月21日
企业认证
相关产品推荐更多 >
EcoPlexTM 小鼠Th1/Th2/Th17细胞7指标多因子试剂盒 | EcoPlexTM Mouse Th1/Th2/Th17 7-Plex Panel Kit
￥16580
人硬骨素(SOST)酶联免疫吸附测定试剂盒 | Human SOST(Sclerostin) ELISA Kit
￥2300人补体因子B(CFB)酶联免疫吸附测定试剂盒 | Human CFB(Complement Factor B) ELISA Kit
￥2300人肾损伤分子1(KIM-1)酶联免疫吸附测定试剂盒 | Human KIM-1(Kidney Injury Molecule 1) ELISA Kit
￥1800人酸性成纤维细胞生长因子(AFGF/FGF1)酶联免疫吸附测定试剂盒 | Human AFGF/FGF1(Acidic Fibroblast Growth Factor 1) ELISA Kit
￥1800
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 供应商：
武汉益普生物科技有限公司
- 检测范围：
0.31-5 μg/mL
- 检测方法：
Colorimetric
- 样本：
Plasma, Serum
- 灵敏度：
0.156 μg/ml
- 规格：
96T
| 产品名 | Epcoritamab ELISA Kit |
| 货号 | KDC90703 |
| 规格 | 96T |
| 别名 | GEN3013, CAS: 2134641-34-0 |
| 检测方法 | Colorimetric |
| 样本类型 | Plasma, Serum |
| 实验类型 | Quantitative |
| 检测范围 | 0.31-5 μg/mL |
| 灵敏度 | 0.156 μg/ml |
| 回收率 | 80-120% |
| 精准度 | CV<20% |
| 背景 | Epcoritamab (DuoBody-CD3xCD20, GEN3013) is a novel bispecific IgG1 antibody redirecting T-cells toward CD20+ tumor cells. Here, we assessed the preclinical efficacy of epcoritamab against primary tumor cells present in the lymph node biopsies from newly diagnosed (ND) and relapsed/refractory (RR) B-NHL patients. In the presence of T-cells from a healthy donor, epcoritamab demonstrated potent activity against primary tumor cells, irrespective of prior treatments, including CD20 mAbs. Median lysis of 65, 74, and 84% were achieved in diffuse large B-cell lymphoma (n = 16), follicular lymphoma (n = 15), and mantle cell lymphoma (n = 8), respectively. Furthermore, in this allogeneic setting, we discovered that the capacity of B-cell tumors to activate T-cells was heterogeneous and showed an inverse association with their surface expression levels of the immune checkpoint molecule Herpesvirus Entry Mediator (HVEM). In the autologous setting, when lymph node (LN)-residing T-cells were the only source of effector cells, the epcoritamab-dependent cytotoxicity strongly correlated with local effector cell-to-target cell ratios. Further analyses revealed that LN-residing-derived or peripheral blood-derived T-cells of B-NHL patients, as well as heathy donor T-cells equally mediated epcoritamab-dependent cytotoxicity. These results show the promise of epcoritamab for treatment of newly-diagnosed or relapsed/refractory B-NHL patients, including those who became refractory to previous CD20-directed therapies. |
| 稳定性和存储 | The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition. |
| 保存方法 | 2-8 ℃ |
| 说明 | For Research Use Only. |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验市面上的 ELISA 试剂盒五花八门，质量良莠不齐。如何浪里淘金，选择既符合科研需求，又品质上乘的 ELISA 试剂盒呢? 教你七招，快速搞定 ELISA 试剂盒的选择！ 01 查找待测样本的蛋白浓度 通过检索 SCI 文献、Genecards、Mayocliniclabs 等，获得目标蛋白的表达部位及表达浓度参考值，比较 ELISA 试剂盒中给出的样本测值与参考值是否一致。 02 明确试剂盒的应用种属＆检测的样本类型 不同厂家验证的样本类型不同。除试剂盒特别说明外，一般情况下，不同
本文主要介绍 ELISA 试剂盒、实验样本、相关问题，帮助大家更好地开展实验 试剂盒 Q1：科研试剂盒与临床试剂盒的区别 ？ A1：临床试剂是经过权威机构认可的，如 FDA、CFDA 等；而科研试剂一般是厂家自主研制，不需要通过权威机构验证。 经营临床诊断类产品的机构需要取得《医疗器械经营企业许可证》；经营科研试剂的机构不需要此证件。 临床试剂盒一般仅用于检测人血清/血浆等较为单一的分泌性样本类型；科研试剂盒的样本检测种类、检测范围则比临床试剂盒宽广得多。但一般来说，临床试剂盒的质量
目前市场上的 ELISA 试剂盒质量参差不齐，如何去挑选适合自己的试剂盒就显得特别重要，具体有以下几点可供参考。 特异性 ELISA 试剂盒的特异性与试剂盒的关键组分，抗体对有关。若抗体对中之一为多抗，另一个必须为单抗，建议使用双单抗。 灵敏度 灵敏度反映的是试剂盒检出被检物质的最低量的能力，用户可根据自己样本中待检指标的量选择合适的试剂盒，如果待检指标量很低，一般的试剂盒不能满足要求，可选择高敏的 ELISA 试剂盒。 重复
技术资料暂无技术资料 索取技术资料
